2000 suplement 3

Back

Volume 9, suplement 3

Terapia

Hyperprolactinaemia in the treatment of schizophrenic twins: case report

WITOLD DUŃSKI1
1. z IV Kliniki Psychiatrycznej Instytutu Psychiatrii i Neurologii w Warszawie
Postępy Psychiatrii i Neurologii, 2000, suplement 3 (11), 139-142
Keywords: hyperprolactinaemia, schizophrenia, risperidone, twins, case report

Abstract

The paper presents the course ofschizophrenia in 27-year-old monozygotic femaletwins with similar symptomatology and response totreatment. In the treatment with risperidone in thedaily dose of 2-3 mg dyskinesia was noted. An ambivalent attitude towards this treatment has notbeen changed when the risperidone dose reached4 mg. In both patients hyperprolactinaemia over2500 mIU/L was found then, as well as galactorrheaand amenorrhea. The treatment with risperidonewas discontinued for this reason. Thetreatment and rehabilitation methods administeredin the years 1994-1999 are discussed. Routinemonitoring of prolactine levels prior to and duringthe treatment with risperidoneis recommended.

Address for correspondence:
Dr Witold Duński: IV Klinika Psychiatrii Instytutu Psychiatrii i Neurologii, Szpital Bródnowski,
ul. Kondratowicza 8, 03-242 Warszawa